Tower Research Capital (TRC)’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.2K | Buy |
1,405
+477
| +51% | +$14K | ﹤0.01% | 3130 |
|
|
2025
Q1 | $23.9K | Sell |
928
-932
| -50% | -$24K | ﹤0.01% | 2803 |
|
|
2024
Q4 | $53.7K | Buy |
1,860
+1,151
| +162% | +$33.2K | ﹤0.01% | 2504 |
|
|
2024
Q3 | $16.8K | Sell |
709
-157
| -18% | -$3.73K | ﹤0.01% | 3345 |
|
|
2024
Q2 | $15K | Buy |
866
+415
| +92% | +$7.18K | ﹤0.01% | 3926 |
|
|
2024
Q1 | $10.1K | Sell |
451
-195
| -30% | -$4.35K | ﹤0.01% | 3748 |
|
|
2023
Q4 | $11.8K | Buy |
646
+12
| +2% | +$220 | ﹤0.01% | 4097 |
|
|
2023
Q3 | $11K | Buy |
634
+178
| +39% | +$3.09K | ﹤0.01% | 4051 |
|
|
2023
Q2 | $8.3K | Sell |
456
-232
| -34% | -$4.22K | ﹤0.01% | 4425 |
|
|
2023
Q1 | $11K | Buy |
688
+386
| +128% | +$6.17K | ﹤0.01% | 4280 |
|
|
2022
Q4 | $7K | Sell |
302
-624
| -67% | -$14.5K | ﹤0.01% | 4636 |
|
|
2022
Q3 | $21K | Buy |
926
+824
| +808% | +$18.7K | ﹤0.01% | 3913 |
|
|
2022
Q2 | $2K | Sell |
102
-295
| -74% | -$5.78K | ﹤0.01% | 5623 |
|
|
2022
Q1 | $14K | Sell |
397
-455
| -53% | -$16K | ﹤0.01% | 3929 |
|
|
2021
Q4 | $74K | Buy |
852
+755
| +778% | +$65.6K | ﹤0.01% | 2452 |
|
|
2021
Q3 | $11K | Buy |
+97
| New | +$11K | ﹤0.01% | 4269 |
|